日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The association of urinary epidermal growth factors with ADPKD disease severity and progression.

尿表皮生长因子与 ADPKD 疾病严重程度和进展的关系

期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfad050
Harskamp Laura R, Perez-Gomez Maria Vanessa, Heida Judith E, Engels Gerwin E, van Goor Harry, van den Heuvel Marius C, Streets Andrew J, Ong Albert C M, Ortiz Alberto, Gansevoort Ron T
发表日期：2023
文献求助 收藏

The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial

托伐普坦对多囊肾病患者血压的影响：TEMPO 3:4试验的事后分析

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.2020101512
Heida, Judith E; Gansevoort, Ron T; Torres, Vicente E; Devuyst, Olivier; Perrone, Ronald D; Lee, Jennifer; Li, Hui; Ouyang, John; Chapman, Arlene B
发表日期：2021
文献求助 收藏

Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression

利用尿液与血浆尿素比值预测ADPKD进展

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.10470620
Heida, Judith E; Gansevoort, Ron T; Messchendorp, A Lianne; Meijer, Esther; Casteleijn, Niek F; Boertien, Wendy E; Zittema, Debbie
发表日期：2021
文献求助 收藏

Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients

常染色体显性多囊肾病患者接受血管加压素V2受体拮抗剂治疗期间的酸碱平衡

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2020.12.021
Heida, Judith E; Gansevoort, Ron T; Meijer, Esther
信号转导
发表日期：2021
文献求助 收藏

Author's Reply to Correspondence: "Effect of Tolvaptan Treatment on Acid-Base Homeostasis in ADPKD Patients"

作者回复来信：“托伐普坦治疗对ADPKD患者酸碱平衡的影响”

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2021.04.014
Heida, Judith E; Gansevoort, Ron T; Meijer, Esther
发表日期：2021
文献求助 收藏

No Change in Nocturia After NOCTURNE

夜曲后夜尿症无变化

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2020.04.014
Meijer, Esther; Heida, Judith E; Gansevoort, Ron T
发表日期：2020
文献求助 收藏